An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Myeloproliferative Neoplasm · MPN · Essential Thrombocythemia · Polycythemia Vera · Myelofibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of California, Irvine, Irvine, California, United States

    Contact: Study coordinator (Angela G Fleischman, MD PhD) · agf@uci.edu · (949) 999-2400
  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

Study leads
  • Angela Fleischman, MD, PhD

    Principal Investigator

    Chao Family Comprehensive Cancer Center